CBR Pharma Market Research Reports

Insight Pharma Reports are written by experts in consulting and industry who collaborate with us to provide a series of reports that evaluate the salient issues in pharmaceutical technology, business, and therapy markets. Insight Pharma Reports are used by leading pharmaceutical, biotech, diagnostic, consulting, and financial companies to keep abreast of the latest advances in pharmaceutical R&D, their potential applications and business impacts, and their current and future position in the marketplace. 

Why purchase an Insight Pharma Report?
Current information on highly relevant topics including biomarkers, pharmacogenomics, molecular diagnostics, predictive toxicology, inflammatory disease therapeutics, metabolic disease therapeutics, and R&D productivity.

Evaluation of the leading trends and breakthroughs within each field, as well as promising early-stage developments.

Analysis of the probability of success for various applications of each technology, and their wider business implications.

Expert insight based on interviews with key personnel in companies at the forefront of technological advances. These experts share their views on their technology's current status, applications in drug development or diagnostics, future direction, and the general market environment.

Competitive insight into the business strategies and activities of key companies. 

Search our comprehensive collection of reports on Markets and Businesses.
Buy reports at huge discounts from leading Market Research companies with deep and extensive industry knowledge.

Use the search box below to find reports.

search:

Featured CBR Pharma Market Research Reports

TitleDate PublishedPrice fromMore Details
Solar Photovoltaic (PV) Market, Update 2016 - Global Market Size, Market Share, Average Price, Regulations and Key Country Analysis to 2025
Solar Photovoltaic (PV) Market, Update 2016 - Global Market Size, Market Share, Average Price, Regul...
14 Jun 2016 by CBR Pharma USD $3,995 More Info
Solar Photovoltaic (PV) in Romania, Market Outlook to 2030, Update 2016 - Capacity, Generation, Levelized Cost of Energy (LCOE), Investment Trends, Regulations and Company Profiles
Solar Photovoltaic (PV) in Romania, Market Outlook to 2030, Update 2016 - Capacity, Generation, Leve...
14 Jun 2016 by CBR Pharma USD $2,500 More Info
Hydropower in Romania, Market Outlook to 2030, Update 2016 - Capacity, Generation, Levelized Cost of Energy (LCOE), Investment Trends, Regulations and Company Profiles
Hydropower in Romania, Market Outlook to 2030, Update 2016 - Capacity, Generation, Levelized Cost of...
14 Jun 2016 by CBR Pharma USD $2,500 More Info
Monthly Upstream Deals Review - May 2016
Monthly Upstream Deals Review - May 2016 Summary GlobalData's “Monthly Upstream Deals Review - M...
16 Jun 2016 by CBR Pharma USD $250 More Info
Brenner Tumor Global Clinical Trials Review, H1, 2016
Brenner Tumor Global Clinical Trials Review, H1, 2016 Summary GlobalData's clinical trial report, ...
15 Jun 2016 by CBR Pharma USD $2,500 More Info
Choriocarcinoma (Gestational Trophoblastic Neoplasia) Global Clinical Trials Review, H1, 2016
Choriocarcinoma (Gestational Trophoblastic Neoplasia) Global Clinical Trials Review, H1, 2016 Summa...
15 Jun 2016 by CBR Pharma USD $2,500 More Info
Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Global Clinical Trials Review, H1, 2016
Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Global Clinical Trials Review, H1, 2016 ...
15 Jun 2016 by CBR Pharma USD $2,500 More Info
Cutaneous B-Cell Lymphoma Global Clinical Trials Review, H1, 2016
Cutaneous B-Cell Lymphoma Global Clinical Trials Review, H1, 2016 Summary GlobalData's clinical tr...
15 Jun 2016 by CBR Pharma USD $2,500 More Info
Chemotherapy Induced Neutropenia Global Clinical Trials Review, H1, 2016
Chemotherapy Induced Neutropenia Global Clinical Trials Review, H1, 2016 Summary GlobalData's clin...
15 Jun 2016 by CBR Pharma USD $2,500 More Info
High-Grade Glioma Global Clinical Trials Review, H1, 2016
High-Grade Glioma Global Clinical Trials Review, H1, 2016 Summary GlobalData's clinical trial repo...
15 Jun 2016 by CBR Pharma USD $2,500 More Info

 

More CBR Pharma Market Research Reports Market Reports

TitleDate PublishedPrice fromMore Details
Chronic Lymphocytic Leukemia (CLL) Global Clinical Trials Review, H1, 201615 Jun 2016 by CBR Pharma USD $2,500 More Info
Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer Global Clinical Trials Review, H1, 201615 Jun 2016 by CBR Pharma USD $2,500 More Info
Chemotherapy Induced Peripheral Neuropathy Global Clinical Trials Review, H1, 201615 Jun 2016 by CBR Pharma USD $2,500 More Info
Chemotherapy Induced Anemia Global Clinical Trials Review, H1, 201615 Jun 2016 by CBR Pharma USD $2,500 More Info
Drug Delivery Infusion Systems - Medical Devices Pipeline Assessment, 201604 Jul 2016 by CBR Pharma USD $4,000 More Info
Cardiac Pacemakers - Medical Devices Pipeline Assessment, 201604 Jul 2016 by CBR Pharma USD $2,500 More Info
Bare Metal Stents (BMS) - Medical Devices Pipeline Assessment, 201604 Jul 2016 by CBR Pharma USD $2,500 More Info
Point-of-Care (POC) Analyzers - Medical Devices Pipeline Assessment, 201604 Jul 2016 by CBR Pharma USD $4,000 More Info
Medical Equipment Monthly Deals Analysis: May 2016 - M&A and Investment Trends14 Jun 2016 by CBR Pharma USD $1,000 More Info
Power Monthly Deal Analysis - May 2016: M&A and Investment Trends15 Jun 2016 by CBR Pharma USD $1,000 More Info
Ghana Power Market Outlook to 2030, Update 2016 - Market Trends, Regulations, and Competitive Landscape16 Jun 2016 by CBR Pharma USD $2,500 More Info
Angola Power Market Outlook to 2030, Update 2016 - Market Trends, Regulations, and Competitive Landscape16 Jun 2016 by CBR Pharma USD $2,500 More Info
Stem Cell Therapies - Global Trends in the Competitive, Technological and R&D Landscape01 Jul 2016 by CBR Pharma USD $2,995 More Info
Prostate Cancer - Pipeline Review, H1 201628 Jun 2016 by CBR Pharma USD $2,500 More Info
Pancreatic Cancer - Pipeline Review, H1 201628 Jun 2016 by CBR Pharma USD $2,500 More Info
Non-Small Cell Lung Cancer - Pipeline Review, H1 201628 Jun 2016 by CBR Pharma USD $2,500 More Info
Ovarian Cancer - Pipeline Review, H1 201628 Jun 2016 by CBR Pharma USD $2,500 More Info
Rheumatoid Arthritis - Pipeline Review, H1 201628 Jun 2016 by CBR Pharma USD $2,500 More Info
Parkinson's Disease - Pipeline Review, H1 201628 Jun 2016 by CBR Pharma USD $2,500 More Info
Neuropathic Pain - Pipeline Review, H1 201628 Jun 2016 by CBR Pharma USD $2,000 More Info
Gastrin/Cholecystokinin Type B Receptor (CCK-B Receptor or Cholecystokinin-2 Receptor or CCKBR) - Pipeline Review, H1 201628 Jun 2016 by CBR Pharma USD $3,500 More Info
Telomerase Reverse Transcriptase (Telomerase or HEST2 or Telomerase Catalytic Subunit or Telomerase-Associated Protein 2 or EC 2.7.7.49) - Pipeline Review, H1 201628 Jun 2016 by CBR Pharma USD $3,500 More Info
T-Cell Surface Glycoprotein CD3 Epsilon Chain (T-Cell Surface Antigen T3/Leu-4 Epsilon Chain or CD3e) - Pipeline Review, H1 201628 Jun 2016 by CBR Pharma USD $3,500 More Info
Glial-Derived Neurotrophic Factor (GDNF) - Pipeline Review, H1 201628 Jun 2016 by CBR Pharma USD $3,500 More Info
Transthyretin (ATTR or Prealbumin or TBPA or TTR) - Pipeline Review, H1 201628 Jun 2016 by CBR Pharma USD $3,500 More Info
Prostaglandin D2 Receptor 2 (Chemoattractant Receptor-Homologous Molecule Expressed On Th2 Cells or G-Protein Coupled Receptor 44 or CD294 or DP2 or PTGDR2) - Pipeline Review, H1 201628 Jun 2016 by CBR Pharma USD $3,500 More Info
Superoxide Dismutase [Cu-Zn](Superoxide Dismutase 1 or Epididymis Secretory Protein Li 44 or EC 1.15.1.1) - Pipeline Review, H1 201628 Jun 2016 by CBR Pharma USD $3,500 More Info
Dual Specificity Tyrosine-Phosphorylation-Regulated Kinase 1A (Serine/Threonine Kinase MNB or MNB/DYRK Protein Kinase or EC 2.7.12.1) - Pipeline Review, H1 201628 Jun 2016 by CBR Pharma USD $3,500 More Info
Glucokinase (Hexokinase-D or Hexokinase Type IV or EC 2.7.1.2) - Pipeline Review, H1 201628 Jun 2016 by CBR Pharma USD $3,500 More Info
Diacylglycerol O-Acyltransferase 1 (Diglyceride Acyltransferase 1 or ACAT-Related Gene Product 1 or Acyl-CoA Retinol O-Fatty-Acyltransferase or EC 2.3.1.20) - Pipeline Review, H1 201628 Jun 2016 by CBR Pharma USD $3,500 More Info
Histone Deacetylase 3 (SMAP45 or EC 3.5.1.98) - Pipeline Review, H1 201628 Jun 2016 by CBR Pharma USD $3,500 More Info
Tyrosine-Protein Phosphatase Non-Receptor Type 1 (Protein-Tyrosine Phosphatase 1B or Protein Tyrosine Phosphatase Placental or EC 3.1.3.48) - Pipeline Review, H1 201628 Jun 2016 by CBR Pharma USD $3,500 More Info
Methionine Aminopeptidase 2 (MAP 2 or Peptidase M 2 or eIF-2-a Associated p67 Homolog or EC 3.4.11.18) - Pipeline Review, H1 201628 Jun 2016 by CBR Pharma USD $3,500 More Info
Carbonic Anhydrase 9 (Carbonate Dehydratase IX or CA-IX or Membrane Antigen MN or P54/58N or Renal Cell Carcinoma-Associated Antigen G250 or EC 4.2.1.1) - Pipeline Review, H1 201628 Jun 2016 by CBR Pharma USD $3,500 More Info
Interleukin 2 (T Cell Growth Factor or Aldesleukin or IL2) - Pipeline Review, H1 201628 Jun 2016 by CBR Pharma USD $3,500 More Info
Interleukin 13 (IL13) - Pipeline Review, H1 201628 Jun 2016 by CBR Pharma USD $3,500 More Info
Placental Growth Factor (PIGF or Vascular Endothelial Growth Factor Related Protein) - Pipeline Review, H1 201628 Jun 2016 by CBR Pharma USD $3,500 More Info
The Future of Generic Drugs and Strategies for Commercial Success01 Sep 2016 by CBR Pharma USD $2,995 More Info
Global Drug Delivery Technologies - Innovation Driven by Rapidly Expanding Injectables Market and Increasing Usage of Complex Biologics during the Forecast Period01 Nov 2016 by CBR Pharma USD $2,995 More Info
Strategic Trends in Private Equity and Venture Capital Funding for Healthcare01 Nov 2016 by CBR Pharma USD $2,995 More Info

 

>> More CBR Pharma Market Research Reports Market Research Reports

CBR Pharma Market Research Reports

You can use this search page to mine our extensive archive of market research and corporate data reports. Type in your search term, company name, market title or other keywords and click return on your keyboard to find matches from our comprehensive library of reports, books and analyses.

  • Visa Credit payments supported by WorldPay
  • Visa Debit payments supported by WorldPay
  • Mastercard payments supported by WorldPay
  • American Express payments supported by WorldPay
  • WorldPay Payments Processing

You can buy reports immediately using our online secure payment service. Payments are processed 100% securely by WorldPay. We accept the following Credit/Debit cards.

Extensive Library of Reports Available

388,243 professional market reports and company analyses now available.

About SPi Reports

We specialise in selling market research and company reports from leading market research publishers. Use our comprehensive search service to find the reports that you're looking for.

Personal Service 

We are based in the UK and are committed to quality customer service. If you need help, contact our sales team for personal assistance: phone +44 (0) 1305 753769 or email office@sectorpublishing.com.